Novarum Office Move

We’ve Moved Office

As the role of mobile technology becomes increasingly important in all our lives, the BBI Group mobile development arm, Novarum DX, is continuing to undergo significant growth. There are a number of exciting initiatives at Novarum which together, with ever-increasing cooperation across the BBI Group, means we have exceeded capacity in our existing premises. To…

ScotlandIS

Novarum join ScotlandIS

Novarum™ DX is the latest member of ScotlandIS – the industry body for the digital technologies sector, representing software, IT, telecommunications businesses and digital agencies. Novarum’s membership will enable the company to network and engage with potential collaborators across the digital technology sector. Polly Purvis, CEO, ScotlandIS: “MedTech is a vibrant and diverse ecosystem within Scotland’s…

European patent granted

Smartphone diagnostic specialist Novarum™ DX has achieved a significant milestone in the development of its revolutionary technology after being officially granted a European patent. Novarum has been awarded the patent (EP 12718728.4) for its smartphone diagnostic technology by the European Patent Office (EPO), having already secured the equivalent patent for its technology in the United…

New Takara lentivirus smartphone test

A leading biotechnology company has developed a rapid test to measure recombinant lentivirus titers using a smartphone as a diagnostic reader. Takara Bio USA, Inc. (TBUSA; formerly Clontech Laboratories, Inc.) teamed up with smartphone diagnostics specialists, Novarum™ DX, to develop an integrated, mobile platform which detects and quantifies recombinant lentivirus in packaging cell supernatants. Novarum’s…

A new digital era for pharma

  Late last year the FDA cleared a pill with an inbuilt ingestion tracking system. Remarkably, the tablets have an inbuilt sensor that is aware when the medication has been taken and data is transmitted to a patch worn outside the body. This lets clinicians know whether patients have been taking the prescribed dose of…